Lv2
158 积分 2026-07-13 加入
CDK9 inhibitor CDKI-73 is synergetic lethal with PARP inhibitor olaparib in BRCA1 wide-type ovarian cancer
9天前
已完结
BET, SRC, and BCL2 family inhibitors are synergistic drug combinations with PARP inhibitors in ovarian cancer
9天前
已完结
Methylated circulating tumor DNA as a potential marker of PARP inhibitor efficiency in BRCA mutated ovarian cancer patients
9天前
已关闭
PBK drives PARP inhibitor resistance through the TRIM37/NFκB axis in ovarian cancer
23天前
已完结
KLF5 Promotes Tumor Progression and Parp Inhibitor Resistance in Ovarian Cancer
23天前
已完结
Evodiamine from Evodia rutaecarpa induces apoptosis via activation of JNK and PERK in human ovarian cancer cells
1个月前
已完结
Chinese herbal extract Astragalus radix potentiates human ovarian cancer cell cytotoxicity by aggravated ROS production and apoptosis
1个月前
已完结
Design and Synthesis of PARP/CDK6 Dual-Target Inhibitors Modulating of Wnt/β-Catenin Signaling Pathway for the Treatment of BRCA Wild-Type TNBC
1个月前
已完结
皖公网安备34019202002308
